A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Herpes Zoster

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

GSK Investigational Site, Brussels, Belgium
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Elise Hennaut)
GSK Investigational Site, Ghent, Belgium
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Agnieszka Prytula)
GSK Investigational Site, Leuven, Belgium
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Brigitte Adams)
GSK Investigational Site, Liège, Belgium
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Quentin Bertrand)
GSK Investigational Site, Bordeaux, France
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Jérôme Harambat)
GSK Investigational Site, Lille, France
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Annie Manucci-Lahoche)
GSK Investigational Site, Marseille, France
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Florentine Garaix)
GSK Investigational Site, Montpellier, France
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Marc Fila)
GSK Investigational Site, Nantes, France
GSK Investigational Site, Paris, France
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Olivia BOYER)
GSK Investigational Site, Paris, France
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Julien Hogan)
GSK Investigational Site, Toulouse, France
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Stéphane Decramer)
GSK Investigational Site, Genova, Italy
GSK Investigational Site, Milan, Italy
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Giovanni Montini)
GSK Investigational Site, Padova, Italy
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Elisa Benetti)
GSK Investigational Site, Roma, Italy
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Isabella Guzzo)
GSK Investigational Site, Torino, Italy
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Roberta Camilla)
GSK Investigational Site, Gdansk, Poland
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Aleksandra Zurowska)
GSK Investigational Site, BaracaldoVizcaya, Spain
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Mireia Aguirre Meñica)
GSK Investigational Site, Espluges de Llobregat, Spain
GSK Investigational Site, HebrOn, Spain
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (XAVIER MARTINEZ GOMEZ)
GSK Investigational Site, Madrid, Spain
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (DANIEL BARRACA NÚÑEZ)
GSK Investigational Site, Madrid, Spain
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (TERESA DEL ROSAL RABES)
GSK Investigational Site, Seville, Spain
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Francisco De la Cerda Ojeda)
GSK Investigational Site, Birmingham, United Kingdom
GSK Investigational Site, Cardiff, United Kingdom
GSK Investigational Site, Glasgow Strathclyde, United Kingdom
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (BEN REYNOLDS)
GSK Investigational Site, London, United Kingdom
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Stephen Marks)
GSK Investigational Site, Manchester, United Kingdom
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Mohan Shenoy)
GSK Investigational Site, Nottingham, United Kingdom
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Jon Jin Kim)
GSK Investigational Site, Southampton, United Kingdom
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Matthew Harmer)

מובילי המחקר

GSK Clinical Trials
Study Director
GlaxoSmithKline

צפייה במקור ב־ClinicalTrials.gov

ניסויים דומים

ניסויים נוספים שמגייסים כעת ועשויים להיות רלוונטיים לפי מצב רפואי, טיפול, שלב או מיקום

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Herpes Zoster

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

Bethesda, United States

Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

Herpes Zoster · mRNA Vaccine

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

Xinjiang, China

A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Herpes Zoster (HZ)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

Wuhan, China

Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage

Herpes Zoster (HZ)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

Zunyi, China